Document is current
Any future updates will be listed below
-
Authors
,
Freedman, Stephen B. https://orcid.org/0000-0003-2319-6192
Williamson-Urquhart, Sarah
Heath, Anna
Pechlivanoglou, Petros
Hopkin, Gareth
Gouin, Serge
Plint, Amy C.
Dixon, Andrew
Beer, Darcy
Joubert, Gary
McCabe, Christopher
Finkelstein, Yaron
Klassen, Terry P.
- License Information
-
More Information
Article History
Received: 9 March 2020
Accepted: 24 April 2020
First Online: 27 May 2020
Ethics approval and consent to participate
: The Conjoint Health Research Ethics Board, University of Calgary, has reviewed and approved the research protocol with the ethics ID REB18–2045<i>.</i> Written informed consent to participate will be obtained from all participants or their parent or legal guardian as appropriate.
: Not applicable.
: SBF has received in-kind (study drug and placebo) support from GlaxoSmithKline and Novartis for the conduct of previous research evaluating the use of ondansetron; no support has been provided for the current study. SBF is also providing consulting services to RedHill Biopharm Ltd. The remaining authors declare no competing interests.
